PREDICT-1 is the first genotype-based registrational trial in dry eye disease (DED), with the potential of delivering a first-in-class precision medicine treatment in DED This FDA-aligned trial ...
Morning Overview on MSN
A daily multivitamin slowed all five epigenetic aging clocks in a randomized trial — people who started biologically older saw the biggest benefit
A standard daily multivitamin, the kind sold at every pharmacy for roughly a dime a dose, slowed biological aging across ...
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce ...
BRUIN CLL-313 is a randomized, open-label, global phase III study comparing the efficacy and safety of pirtobrutinib, a highly selective, noncovalent Bruton tyrosine kinase inhibitor (BTKi), against ...
A randomized clinical trial conducted across five countries in 47 pediatric emergency departments, including Ann & Robert H.
Amai Proteins announces another milestone for sweelin®. The world's first human clinical trial on the metabolic effects of sweet proteins is now published by Food Chemistry journal, one of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results